Pretreatment serum alpha fetoprotein and its relation to sustained virologic response in patients with chronic HCV infection treated with direct-acting antiviral therapy - Egyptian Knowledge Bank - troweb

80655

Pretreatment serum alpha fetoprotein and its relation to sustained virologic response in patients with chronic HCV infection treated with direct-acting antiviral therapy

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

A Study of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Received Direct Acting Antiviral Drugs

Article

Predictors of Sustained Virological Response in Chronic Hepatitis C Patients Treated with Current Direct Acting Antiviral Drugs

Article

Hepatocellular Carcinoma in Hepatitis C Virus Cirrhosis After Treatment with Direct Acting Antiviral Therapy

Article

Predictive value &changes in Child-Pugh score in chronic hepatitis C cirrhotic patients treated with Direct Acting Antiviral agents

Article

Prospective Study of Changes in Anti-HCV Immunoglobulin G Antibody Titers after Treatment with Direct Acting Antiviral Agents

Article

Assessment of Degree of Fibrosis in Chronic Hepatitis C Virus Patients Treated with Direct Acting Antiviral Agents

Article

Assessment of Incidence of Hepatocellular Carcinoma among Hepatitis C Patients Who Achieved Sustained Virological Response with Direct Acting Antiviral Agents (DAAs)

Article

Response to Hepatitis B Vaccine in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals

Article

Frequency of Hepatocellular Carcinoma in HCV Patients Treated with Direct-Acting Antiviral Drugs

Article

Long-term Follow-up of Chronic Hepatitis C Patients Treated by Direct- Acting Antivirals